Much like home health and hospice, pharmacy services providers have been consolidating for many years. And yet, go-forward opportunity remains. A pipeline of emerging therapies that, in some cases, have transformed once fatal ailments into chronic conditions that can be managed with specialty drugs, have enabled providers to go from start-up to $100 million seemingly overnight. And with its far greater margins, traditional home infusion therapy still gets its share of attention. That said, demand far exceeds supply, creating challenges for buyers – and unique opportunities for sellers.